Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SNRPGP5 (small nuclear ribonucleoprotein polypeptide G pseudogene 5) is classified as a pseudogene derived from a gene encoding a core protein of the spliceosomal small nuclear ribonucleoprotein (snRNP) complex, specifically the SNRPG protein. Pseudogenes such as SNRPGP5 typically do not produce functional proteins and are not considered biological drug targets, enzymes, receptors, or transporters. Functional snRNP proteins play critical roles in pre-mRNA splicing, but the pseudogene variants generally lack transcription or translation into biologically active proteins. There is no evidence that SNRPGP5 is involved in recognized biological functions, disease associations, drug interactions, or serves as a biomarker or therapeutic target. Additional context: While related snRNP proteins are involved in the assembly and function of the spliceosome (an essential cellular macromolecular complex that removes introns from pre-mRNA), pseudogenes themselves are genetically inactive remnants without biological activity or function in health or disease. Consequently, SNRPGP5 should not be considered a valid drug target or functionally relevant molecule for therapeutic development. If your intent was to ask about the functional SNRPG protein or another snRNP component, clarification or correction of the target name would be required to provide information relevant to drug targeting or signaling biology.
None (pseudogene)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide G pseudogene 5 (SNRPGP5).